Verastem Capex Per Share from 2010 to 2024

VSTM Stock  USD 4.57  0.52  12.84%   
Verastem Capex Per Share yearly trend continues to be very stable with very little volatility. Capex Per Share is likely to drop to 0.0003. During the period from 2010 to 2024, Verastem Capex Per Share quarterly data regression pattern had sample variance of  1.96 and median of  0.03. View All Fundamentals
 
Capex Per Share  
First Reported
2010-12-31
Previous Quarter
0.000365
Current Value
0.000347
Quarterly Volatility
1.40108707
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Verastem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Verastem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.9 K, Interest Expense of 5 M or Selling General Administrative of 35.8 M, as well as many indicators such as Price To Sales Ratio of 35.54, Dividend Yield of 0.0 or PTB Ratio of 3.29. Verastem financial statements analysis is a perfect complement when working with Verastem Valuation or Volatility modules.
  
Check out the analysis of Verastem Correlation against competitors.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.

Latest Verastem's Capex Per Share Growth Pattern

Below is the plot of the Capex Per Share of Verastem over the last few years. It is Verastem's Capex Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Verastem's overall financial position and show how it may be relating to other accounts over time.
Capex Per Share10 Years Trend
Very volatile
   Capex Per Share   
       Timeline  

Verastem Capex Per Share Regression Statistics

Arithmetic Mean0.70
Geometric Mean0.03
Coefficient Of Variation199.62
Mean Deviation0.95
Median0.03
Standard Deviation1.40
Sample Variance1.96
Range4.0689
R-Value(0.07)
Mean Square Error2.10
R-Squared0.01
Significance0.79
Slope(0.02)
Total Sum of Squares27.48

Verastem Capex Per Share History

2024 3.47E-4
2023 3.65E-4
2022 3.17E-4
2021 0.0135
2020 0.002583
2019 0.001126

About Verastem Financial Statements

Verastem investors utilize fundamental indicators, such as Capex Per Share, to predict how Verastem Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports:
Check out the analysis of Verastem Correlation against competitors.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.54)
Revenue Per Share
0.331
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.47)
Return On Equity
(1.37)
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.